Reduced‐volume radiotherapy versus conventional‐volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open‐label, noninferiority, multicenter, randomized phase 3 trial

Documenti analoghi

• Treatment adaptation based on response to induction chemotherapy in nasopharyngeal carcinoma: An evolving landscape
  di: Nadia A. Saeed, et al.
  Pubblicazione: (2025)
• Aumolertinib with carboplatin–pemetrexed versus aumolertinib for nonsmall cell lung cancer with EGFR and concomitant tumor suppressor genes (ACROSS2): An open‐label, multicenter, randomized phase 3 study
  di: Jian‐Chun Duan, et al.
  Pubblicazione: (2026)
• Study assesses normal tissue effects after axillary radiotherapy for early breast cancer
  di: Carrie Printz
  Pubblicazione: (2025)
• Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS‐1): A multicenter, randomized, double‐blind, placebo‐controlled phase 3 trial
  di: Lingying Wu, et al.
  Pubblicazione: (2025)
• Global cancer statistics for children: Two decades of change and projections to 2050
  di: Wangzhong Li, et al.
  Pubblicazione: (2026)